ORC Expert Advisory Services ORC International

  home    |    find an expert    |    request an expert    |    join our network    |    about us     expert login  
Expert Consulting and Expert Witness Services
  
  search tips 
Share this page:  Send to LinkedIn Send to Facebook Tweet This Email Print

 Expert  730074

Expert in Clinical Epidemiology, Public Health Medicine, Drug Safety, Clinical Trials


Available for your Consulting and Expert Witness Needs

United Kingdom
Education Work History Career AccomplishmentsPublicationsConsulting Services Expert Witness Market Research

Summary of Expertise:

Listed with other top experts in: 

Expert is Director of Pharmacoepidemiology in a Public Health Consultancy providing advice and expertise to the public, regulators and medical professionals on the evaluation and safety monitoring of drugs in the European Community. He has: conducted state-of-the-art pharmacoepidemiological studies including electronic healthcare database studies, and studies with de novo data collection; undertaken Strategic Reviews for Clients related to Regulatory requirements, Drug Safety, Market Access and Product Positioning and designed information and analysis plans for Regulators and Clients to meet specific safety questions including post-marketing regulatory requirements for safety surveillance and Physician Compliance to label; he has designed and conducted relative effectiveness studies. He has excellent working knowledge of European databases and networks. He is Honorary Senior Lecturer in Epidemiology at Faculty of Medicine, Imperial College London; Co-Principal Investigator on £20M Health Monitoring Programme for British Police Force. He has strong interests in cancer, cardiovascular, perinatal and vaccine epidemiology and expertise in the design, management and implementation of various kinds of epidemiological research including randomized controlled trials, case control, cohort, and spatio-temporal analyses of large observational datasets. He has published in international journals and presented to a wide variety of audiences including the Royal Society, Drug Information Association (DIA), the ICBD and WHO International Symposium on Prevention & Epidemiology of Congenital Malformations, Maxillofacial Surgical unit at Great Ormond Street Hospital and is member of the: International Society for Pharmacoepidemiology (ISPE), European Medicine Agency (EMA) Steering Group on PROTECT; EMA ENCePP; UK Faculty of Public Health Medicine.
 • 

biostatistics

 • 

cancer epidemiology

 • 

epidemiology

 • 

occupational epidemiology

 • 

pharmacoepidemiology

 • 

reproductive epidemiology


Show Secondary and Basic Areas of Expertise

Education:
Year   Degree   Subject   Institution   Honors
1987   BSc   Biochemistry   Imperial College London   2:1 (Upper)
1998   MSc   Epidemiology and Public Health   London School of Hygiene and Tropical Medicine   Distinction
2001   PhD   Epidemiology and Public Health   Imperial College London   Completed, with minor corrections

Work History:
Years   Employer   Department   Title   Responsibilities

2010 to

 

(Undisclosed)

 


 

Director

 

Head of Unit on Benefit-Risk assessment of licensed Medicines in Europe

2007 to 2010

 

i3 Drug Safety, United Health Care

 


 

Senior Epidemiologist

 

Senior researcher on Benefit-Risk assessment of licensed Medicines in Europe and USA

2003 to 2007

 

Department of Epidemiology & Public Health

 

Faculty of Medicine, Imperial College London

 

Senior Lecturer

 

Senior Lecturer and Course Organizer at Imperial College Faculty of Medicine, London

2002 to 2003

 

Department of Epidemiology & Public Health

 

Faculty of Medicine, Imperial College London

 

Research Fellow in Epidemiology

 

Senior researcher in Epidemiology at Imperial College Faculty of Medicine, London

2001 to 2002

 

Department of Epidemiology & Public Health

 

Faculty of Medicine, Imperial College London

 

Research Associate

 

Research Associate in the Small Area Health Statistics Unit (SAHSU) at the Department of Epidemiology & Public Health, Faculty of Medicine, Imperial College London. Conducted numerous large-scale state-of-the epidemiological studies.


Career Accomplishments:
Associations/Societies

Member of the International Society of Pharmacoepidemiology (ISPE); Member of the UK Faculty of Public Health (MFPH); Member of the Pharmaceutical Information and Pharmacovigilance Association (PIPA); Member of the Drug Information Association (DIA)


Publications:
Publications and Patents Summary

He has written over 100 peer review publications and scientific reports.

Selected Publications and Publishers  
 - Occupational and Environmental Medicine  
 - Epidemiology  
 - Pediatric Critical Care Medicine  
 - DNA Repair  
 - American Journal of Epidemiology  

Government Experience:
Years   Agency   Role   Description
2003 to 2007   Home Office UK   Principal Investigator   Expert was responsible for overseeing a National Health Screening Programme for the British Police Force, under the supervision of the Home Office, UK Government

Consulting Services:
Click the green button above to contact Expert for a free initial screening call regarding your expert consulting needs.  Expert is available for consulting to corporate, legal and government clients.  Remember, your initial screening call to speak with Expert is free.

Expert Witness:
Expert Witness Experience Summary:
Expert acted as Expert Witness to the Leicestershire Police Force in providing an assessment of the potential association between occupational radio use and cancer (2004)
Click the green button above to contact Expert for a free initial screening call regarding expert testimony, litigation consulting and support, forensic services, or any related expert witness services.  A few litigation needs include product liability, personal injury, economic loss, intellectual property (patent, trademark, trade secret, copyright), and insurance matters.  Remember, your initial screening call to speak with Expert is free.

Market Research:
Expert has designed information and analysis plans with Pharmaceutical Clients to meet specific Safety Questions including post-marketing regulatory requirements for safety surveillance and physician compliance to label. He has implemented EU-RMP Epidemiological review of disease (indication) and adverse drug reactions for European Clients. He has undertaken Strategic Reviews for Clients related to Regulatory requirements for drugs, Safety Assessments, Market Access and Product Positioning (based on considerations such as Disease significance, Relative Effectiveness and Population characteristics). He has designed and conducted Relative Effectiveness studies and helped Clients with responses to Regulatory Agencies. He has Conducted state-of-the-art prospective and retrospective studies including prospective studies with de novo data collection. In particular, he worked as lead study Principal Investigator and Epidemiologist on large prospective phase IV studies for Pfizer, BMS, Johnson and Johnson, Sanofi Pasteur and NovoNordisk. He has worked extensively with the Pharmaceutical Industry in a consulting capacity advising on methodologies and scientific study designs. He has excellent knowledge of US and European databases and research networks – e.g. Proprietary Ingenix RDM, Premier Inc. Perspective TM Comparative Database, GPRD, THIN, Danish Population-based Registers, Prescribed Drug Registry, EPIC (European Cancer Register ½ Million Cohort), UK BSR Biologics Register (Rheumatoid Arthritis), UK Biobank. He has strong background in pediatric and cancer epidemiology; investigated relationship between maternal exposure to drugs in first trimester and pregnancy outcome at Imperial (in particular, NTDs and antiepileptic drugs); lead researcher at Imperial on lymphoma. A Summary of therapeutic areas within which he has particular expertise: cancer (lymphoma, lung, gastro-esophageal), CNS, hepatic injury, cardio-vascular and vaccine development. He is a Drug Information Association (DIA) Clinical Forum conference speaker: Practical use of Pharmacoepidemiology in Clinical Drug Development (Ljubljana Oct 20-23, 2008). He is also a member of the UK Pharmaceutical Information and Pharmacovigilance Association (PIPA), ENCePP, EMA PROTECT and Member of UK Faculty of Public Health Medicine (MFPH).



Click the green button above to contact Expert for a free initial screening call regarding your marketing research, industry research, and company research needs.  For research needs involving multiple experts or secondary research, a Research Director can be assigned to coordinate the work into a custom report for you as a potentially quicker and more cost effective alternative to doing this work yourself or hiring a boutique consultancy.  Remember, your initial screening call to speak with Expert is free.


Additional Skills and Services:
Training/Seminars

Expert was Course Organizer and Senior Lecturer at Imperial College Faculty of Medicine, London (2003-2007). His teaching included: International Health (module 1 of MBBS BSc Epidemiology and International health); Health Screening (MSc Modern Epidemiology); Tools of Clinical Science (4th year MBBS BSc medical students); Advanced Topics in Bio-Medicine: Module on Genes and the Environment (4th year MBBS BSc medical students); Randomized Controlled Trials (1st & 2nd year MBBS medical students); Critical Appraisal Skills (1st & 2nd year MBBS medical students); Epidemiology (1st & 2nd year MBBS medical students)

Other Skills and Services

He worked on WHO Oral Polio Virus Vaccination (OPV) Projects (Africa); as a Field Officer for several mass vaccination programmes (MVPs); and was involved in determining OPV immunogenicity in MVPs compared to routine immunization by collecting serum samples and assessing type-specific seropositive rates (1993-1997). He is Co-Principal Investigator of the UK-government sponsored British Police Health Monitoring Programme (240,000 personnel); he wrote the tender and ethics/consent documents, data collection and Health Screening SOPs; managed large team (40 staff members); in charge of nurse training; led executive Force meetings with Police Chief Constables, Heads of Department (HR and Occupational Health); reported to Home Office Steering Committee. He was Involved in the successful design and pilot of National Cohort Programme to assess Mobile Phone Use and long-term Health (focus particularly on brain cancer and neurodegenerative diseases). He presented his findings to Royal Society in London. He was involved in the design, management and analysis of studies on risk factors associated with Neural Tube Defect (NTD), Down Syndrome and Cleft lip/palate-affected pregnancies in England and Wales; his work was done in collaboration with Great Ormond Street Hospital, the National Congenital Anomaly Register and National Down Syndrome Cytogenetics Register. He wrote the successful proposal and supervised £1M Bio-repository build at Hammersmith Hospital, Imperial College, London. He has substantial experience of analyzing large complex databases e.g. Proprietary Ingenix RDM (c.12 million US health plan members with medical and prescription benefit coverage), Premier Inc. Perspective TM Comparative Database (US hospital clinical and economic database), UK General Practice Research Database (GPRD) (longitudinal medical records from primary care), European Prospective Investigation of Cancer (EPIC) & UK National Congenital Anomaly databases, Swedish Prescribed Drug Registry (and related cancer, mortality and census databases), Danish Registry data


 

Need the right expert?  We can help!

home       find an expert       request an expert       join our network       about us

Intota is now ORC Expert Advisory Services

FOLLOW ORC ON